Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
OPHLY ONO PHARMACEUTICAL CO UNSP ADR REPR 0.3333 ORD
8.360
-0.180-2.11%
YOY
Do not show
Hide blank lines
(Q2)2022/09/30(Q1)2022/06/30(FY)2022/03/31(Q4)2022/03/31
Total revenue
26.83% 109.98B 22.16% 106.72B 16.84% 361.36B 20.95% 89.93B
Operating revenue
26.83% 109.98B 22.16% 106.72B 16.84% 361.36B 20.95% 89.93B
Cost of revenue
17.60% 26.78B 18.15% 26.94B 9.28% 93.51B 17.79% 22.88B
Gross profit
30.12% 83.21B 23.58% 79.79B 19.73% 267.85B 22.07% 67.05B
Operating expense
15.55% 41.1B 19.70% 41.62B 31.32% 164.65B 18.66% 46.03B
Selling and administrative expenses
13.46% 21.22B 14.62% 21.73B 11.31% 77.06B -6.88% 19.57B
-General and administrative expense
13.46% 21.22B 14.62% 21.73B 11.31% 77.06B -6.88% 19.57B
Research and development costs
16.81% 20.22B 27.34% 19.41B 21.63% 75.88B 42.50% 26.42B
Other operating expenses
-70.00% 12M -22.37% 590M 557.25% 12.7B -9.21% 276M
Operating profit
48.38% 42.11B 28.09% 38.16B 4.95% 103.2B 30.28% 21.03B
Net non-operating interest income expense
-385.11% -134M -13.13% 880M -28.17% 1.84B -474.19% -348M
Non-operating interest income
-38.10% 65M -11.93% 1.16B 0.63% 2.71B 74.75% 173M
Non-operating interest expense
243.10% 199M -7.92% 279M 537.96% 874M 8,583.33% 521M
Other net income (expense)
Income before tax
47.67% 41.98B 26.74% 39.04B 4.10% 105.03B 27.38% 20.68B
Income tax
46.19% 9.06B 42.05% 9.51B -4.14% 24.34B -35.88% 4.66B
Net income
48.09% 32.91B 22.48% 29.53B 6.87% 80.68B 78.68% 16.02B
Net income continuous Operations
48.09% 32.91B 22.49% 29.53B 6.87% 80.69B 78.67% 16.02B
Minority interest income
420.00% 52M 50.00% 51M 130.56% 166M 372.00% 118M
Net income attributable to the parent company
47.92% 32.86B 22.44% 29.48B 6.75% 80.52B 77.88% 15.9B
Preferred stock dividends
Other preferred stock dividends
0 0 0 0
Net income attributable to common stockholders
47.92% 32.86B 22.44% 29.48B 6.75% 80.52B 77.88% 15.9B
Basic earnings per share
51.20% 22.4311 25.17% 20.1213 7.33% 54.0579 81.91% 10.8589
Diluted earnings per share
51.24% 22.4311 25.18% 20.118 7.33% 54.0479 81.96% 10.8556
Dividend per share
0 0 5.32% 17.6438 -8.09% 8.4284
Currency Unit
JPYJPYJPYJPY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
CEO: Mr. Gyo Sagara
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist